Policy · 115th Congress
HHS Pick at Odds With Trump’s Rhetoric on Drug Prices
But Azar, who led drugmaker Eli Lilly and Co.’s United States operations from 2012 until earlier this year, has contributed significantly to the pharmaceutical industry political spending that the